Disease | severe combined immunodeficiency |
Comorbidity | C0235974|pancreatic cancer |
Sentences | 1 |
PubMedID- 25596375 | scid mice with intraperitoneal human pancreatic cancer panc-1 tumor implants were given a single cycle of 35 microg iv l-ip-tk, or four cycles of 1, 10, 20, 30, or 35 microg iv l-ip-tk (n = 20 per group), followed by intraperitoneal gcv. |
Page: 1